RT @DE2344: @idiot3_the @Monkeypoxtally Sources: Zaire 2014: https://t.co/3NitGfSRHF
@idiot3_the @Monkeypoxtally Sources: Zaire 2014: https://t.co/3NitGfSRHF
@myownmind17 @patriotsongs1 Yes, it did kill more people once mutated. https://t.co/aw7BiOT6py https://t.co/OgteaIxFc5
In 2016, Andersen and Rambaut co-authored a paper about a critical mutation in the glycoprotein of Ebola virus. Back then, they tested infectivity of 5 different EBOV glycoprotein mutants on 3 different cell types. https://t.co/olWQ9mflgy
@AlpehFan @AndrewDirks1 @stevenator_nino @fibke @AndrewDirks1 is correct. @AlpehFan's statements are incorrect in all respects. Just a taste of the huge amount of evidence available: https://t.co/trKmfdeaQL https://t.co/GNOP2i3DdR https://t.co/t8hYHkfc6K
@Blastwizard Thanks for the paper! I’d only found this preceding one which they cast doubt upon… They don’t seem to go so far as to claim it actually got less virulent though, just that things are less clear-cut after subsequent studies? https://t.co/aMuMi
@PeaseRoland @GuptaR_lab @Tuliodna @AllieGreaney Right on, @PeaseRoland You get it! “Deja vu all over again” has served virus evolution seminar titles well. It was eerily similar with - Ebola virus in West Africa, https://t.co/K6BLzhLuVV - the big DRC Ebo
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
RT @LubanLab: NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC out…
NIH-funded postdoc position available to study the structure of Ebola virus glycoprotein variants from West African & DRC outbreaks. #CryoEM #HumanAdaptation Apply here: https://t.co/Cvp8YMo0Pi https://t.co/K6BLzhLuVV
RRIDs were included in the Cell paper "Ebola Virus Glycoprotein with Increased Infectivit…" (https://t.co/tmq0IwaME0). Thank you for making your #methodsmatter. #accelerateopenscience
The authors of "Ebola Virus Glycoprotein with Increased Infectivit…" (https://t.co/tmq0IwaME0) included RRIDs in their paper! Thank you for making your #methodsmatter. #reproducibility
@magnitudinibus @DavidSacks 2 counter examples: spanish flu and Ebola. https://t.co/64C4uWF92G https://t.co/wq5j8qGmAJ https://t.co/ugIQU9jmpd
@watkinson137 Ummm, yes. Ebola mutated in 2014 to be more deadly. Can you stop spreading the misinformation now? https://t.co/bNghnd9Lxv Also, SARS-CoV-2 mutated LAST YEAR (B.1.1.7) to be more deadly. Viruses mutate all the time to outpace the immune syst
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
RT @NathanGrubaugh: @edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (…
@edwardcholmes @MaryPetrone10 @NatureMicrobiol 9/n E.g. during the Ebola epidemic in West Africa, we found a mutation (GP-A82V) that increased infection of human cells. But! we didn't find differences in viral titers or mortality rates. Knowing this during
@remembermerk @K_G_Andersen Yes, that is why we studied it. but our results do not imply that it made ebola deadly, it was already pretty "bad" before A82V. https://t.co/Ug8sMGq9b8 P.S. evolutionary rate, not mutation rate.
RT @NatureEcoEvo: Sylvia Gandon is talking about Ebola emergence and possible evolution. Here's the background: https://t.co/nFH4pOgdE7 htt…
Sylvain Gandon, obviously! #RSCRISPREcologyEvolution
Sylvia Gandon is talking about Ebola emergence and possible evolution. Here's the background: https://t.co/nFH4pOgdE7 https://t.co/BRsedM7Ed0 https://t.co/OXjQL2iqGf #RSCRISPREcologyEvolution
RT @BurkeLabRNA: JournalClub paper for @BurkeLabRNA, ahead of Ted Diehl's visit to @Mizzou next week. #Ebola Virus Glycoprotein with Incr…
JournalClub paper for @BurkeLabRNA, ahead of Ted Diehl's visit to @Mizzou next week. #Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic https://t.co/G76rT3v8iq (Featured on #TWiV episode 415: https://t.co/jX853uahIC @
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic. https://t.co/90BwWB49Sw
RT @atulbutte: Just heard about big @K_G_Andersen @ScrippsSTSI Ebola Cell paper, studied mutation timeline & viral infectivity! https://t.c…
RT @atulbutte: Just heard about big @K_G_Andersen @ScrippsSTSI Ebola Cell paper, studied mutation timeline & viral infectivity! https://t.c…
Just heard about big @K_G_Andersen @ScrippsSTSI Ebola Cell paper, studied mutation timeline & viral infectivity! https://t.co/onK0hEjmcZ
RT @drbrainbugz: The Ebolavirus mutation A82V allows it to better infect primate cells and is associated with increased severity: https://t…
The Ebolavirus mutation A82V allows it to better infect primate cells and is associated with increased severity: https://t.co/qvZxTic75w
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZY…
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic: Cell #ucshrewsbury https://t.co/ZJd5TW5ISP
RT @rich_urbanowicz: Paper https://t.co/yb4neKvjzt adding more evidence for adaptive changes during the outbreak https://t.co/zrnCB1oUGO ht…
Paper https://t.co/yb4neKvjzt adding more evidence for adaptive changes during the outbreak https://t.co/zrnCB1oUGO https://t.co/mAJJx8VF5W
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/ZFA5Bp8TN5
RT @miltenyibiotec: From Cell, researchers investigate an #Ebola virus mutation during the last epidemic, using #CD14 MicroBeads https://t.…
From Cell, researchers investigate an #Ebola virus mutation during the last epidemic, using #CD14 MicroBeads https://t.co/FkOLnIcUw5
@irenedelse https://t.co/2pjvFSBUat & https://t.co/Cqd6nyBsZL je fais aussi du calcul et jaime bien te voir tirer la langue, tu vas bien ?
@lyrusi regarde bien la date de publication des articles scientifiques : https://t.co/4xCy4DxARM et https://t.co/mfzp1E5MLb
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/3CYlfTEyhA
RT @Virus_Evolution: Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic (paywalled). https://t.co/3gWZMHD…
@anniezeanbean @HealthyLiving You can find the link to the study embedded in the article. https://t.co/iYLqxqqCOn
RT @Virus_Evolution: Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic (paywalled). https://t.co/3gWZMHD…
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 https://t.co/MFIyMNdYWL
RT @Virus_Evolution: Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic (paywalled). https://t.co/3gWZMHD…
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic (paywalled). https://t.co/3gWZMHD1CC https://t.co/rkAGLyL7HK
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZ…
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZ…
Evolution following a host-jump https://t.co/BQ6pIXKJVE
RT @BurkeLabRNA: 1/3 Two great #EbolaVirus papers in Cell this week. First, increased infectivity by GP mutant in 2013-16 West Africa epide…
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/sBrn1ItPQi
RT @BurkeLabRNA: 1/3 Two great #EbolaVirus papers in Cell this week. First, increased infectivity by GP mutant in 2013-16 West Africa epide…
1/3 Two great #EbolaVirus papers in Cell this week. First, increased infectivity by GP mutant in 2013-16 West Africa epidemic. https://t.co/OjeUe4ujJ9
RT @TeDoyMiPalabra: #EnDirecto @aberron nos cuenta que el Genoma del Ébola aprendió de nosotros https://t.co/Nr0P7TlULf 😱
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZY…
#Ebola virus adaptations studied through observing the effects of GP-A82V mutation on EBOV virulence. https://t.co/OLryWowXOy https://t.co/QlijiI8C1h
RT @TeDoyMiPalabra: #EnDirecto @aberron nos cuenta que el Genoma del Ébola aprendió de nosotros https://t.co/Nr0P7TlULf 😱
#EnDirecto @aberron nos cuenta que el Genoma del Ébola aprendió de nosotros https://t.co/Nr0P7TlULf 😱
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZY…
2014にEBOV糖タンパクが好ヒト化変異(GP-A82V): The University of Nottingham/University of Massachusetts https://t.co/cpQfltRrx0 https://t.co/1rB9jCLeyu
Very interesting article about #EBOV adapting to humans @LubanLab https://t.co/5aeN0CFDe4
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZY…
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZ…
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZ…
RT @mmw_lmw: #EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZ…
#EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZY https://t.co/LyZIwcqx6z
#EbolaV | Virus glycoprotein mutant dominated recent epidemic | Andersen Sabeti & Luban @CellCellPress https://t.co/3uV0oR5OZY https://t.co/qFXSMYSQLe
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/oFGrzL0aGz
رغم فترة حياته القصيرة، فقد تم رصد حالات تطّفّر لفيروس #ايبولا مؤخراً تمكنه من الانتشار بين البشر بشكل غير مسبوق!! https://t.co/luY5TbJy4t
Mutation in #Ebola, GP-A82V, provides increased infectivity in primates/humans. Dominated '13-'16 outbreak https://t.co/XTPtxFW5Z2
RT @edwardwrightuk: Adaption of #Ebola during WA outbreak https://t.co/HycgqmFzqD https://t.co/qW5yxLWOoU. Nice pheno data from @rich_urban…
RT @PardisSabeti: Tx @LubanLab @K_G_Andersen @JonathanKBall Implications of our study terrifying, but science together inspiring. https://…
RT @edwardwrightuk: Adaption of #Ebola during WA outbreak https://t.co/HycgqmFzqD https://t.co/qW5yxLWOoU. Nice pheno data from @rich_urban…
RT @edwardwrightuk: Adaption of #Ebola during WA outbreak https://t.co/HycgqmFzqD https://t.co/qW5yxLWOoU. Nice pheno data from @rich_urban…
RT @VignuzziLab: New work from the @LubanLab!: Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https:/…
#Ebola virus glycoprotein mutant with increased infectivity dominated the recent epidemic https://t.co/YNubLoPi91 + https://t.co/RHY1rgrG4a https://t.co/Pbk3R20BzF
RT @RobinMay9: Remarkable & scary example of #ebola evolution, from @PardisSabeti et al: https://t.co/V7UVp6TjMu #BIOM23 students, you sh…
November 3, 2016 1102p EDT Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/IPlUCRXG1m
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/LFyOn9fv4e
#Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic https://t.co/y9fDnc2N0F
RT @PardisSabeti: Tx @LubanLab @K_G_Andersen @JonathanKBall Implications of our study terrifying, but science together inspiring. https://…
RT @RobinMay9: Remarkable & scary example of #ebola evolution, from @PardisSabeti et al: https://t.co/V7UVp6TjMu #BIOM23 students, you sh…
Remarkable & scary example of #ebola evolution, from @PardisSabeti et al: https://t.co/V7UVp6TjMu #BIOM23 students, you should read this